J. L. Harousseau

1.5k total citations
35 papers, 812 citations indexed

About

J. L. Harousseau is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, J. L. Harousseau has authored 35 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in J. L. Harousseau's work include Multiple Myeloma Research and Treatments (13 papers), Acute Myeloid Leukemia Research (8 papers) and Cancer Treatment and Pharmacology (7 papers). J. L. Harousseau is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Acute Myeloid Leukemia Research (8 papers) and Cancer Treatment and Pharmacology (7 papers). J. L. Harousseau collaborates with scholars based in France, Italy and Poland. J. L. Harousseau's co-authors include Philippe Moreau, Nöel Milpied, Michel Attal, Hervé Avet‐Loiseau, Pascaline Talmant, Richard Garand, Steven Le Gouill, Fanny Gaillard, Nadine Juge‐Morineau and Cyrille Touzeau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

J. L. Harousseau

35 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. L. Harousseau France 14 436 293 199 187 163 35 812
G. J. Ossenkoppele Netherlands 18 309 0.7× 308 1.1× 164 0.8× 269 1.4× 135 0.8× 51 832
A.-M. Stoppa France 14 537 1.2× 484 1.7× 218 1.1× 240 1.3× 130 0.8× 22 970
E. Papageorgiou Greece 20 341 0.8× 278 0.9× 160 0.8× 252 1.3× 220 1.3× 48 866
P Coser Italy 15 490 1.1× 339 1.2× 149 0.7× 324 1.7× 215 1.3× 38 914
Takafumi Matsushima Japan 17 417 1.0× 200 0.7× 157 0.8× 266 1.4× 263 1.6× 57 933
SN Wolff United States 10 421 1.0× 397 1.4× 133 0.7× 277 1.5× 229 1.4× 13 822
Bernadette Corront France 15 464 1.1× 266 0.9× 155 0.8× 327 1.7× 258 1.6× 28 797
Roberto Sorasio Italy 14 542 1.2× 291 1.0× 286 1.4× 210 1.1× 83 0.5× 33 853
Neil Kogut United States 18 352 0.8× 495 1.7× 111 0.6× 349 1.9× 116 0.7× 52 914
Carmen Pedro Spain 15 392 0.9× 301 1.0× 162 0.8× 413 2.2× 314 1.9× 27 885

Countries citing papers authored by J. L. Harousseau

Since Specialization
Citations

This map shows the geographic impact of J. L. Harousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Harousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Harousseau more than expected).

Fields of papers citing papers by J. L. Harousseau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. L. Harousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Harousseau. The network helps show where J. L. Harousseau may publish in the future.

Co-authorship network of co-authors of J. L. Harousseau

This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Harousseau. A scholar is included among the top collaborators of J. L. Harousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Harousseau. J. L. Harousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harousseau, J. L., Hervé Avet‐Loiseau, J. Y. Mary, et al.. (2010). Bortezomib Plus Dexamethasone Versus Reduced-dose Bortezomib Plus Thalidomide-dexamethasone As Induction Prior To Autologous Transplantation in Newly Diagnosed Myeloma. 95. 451. 4 indexed citations
2.
Brissot, Éolia, P. Chevallier, T. Guillaume, et al.. (2009). Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors. Bone Marrow Transplant. 1 indexed citations
3.
4.
Guillaume, Thierry, Nelly Robillard, Hervé Avet‐Loiseau, et al.. (2008). Human chimeric anti-CD44 antibody ARH460–16–2 binds leukemic cells and malignant plasma cells. Journal of Clinical Oncology. 26(15_suppl). 14010–14010. 1 indexed citations
5.
Harousseau, J. L., Claire Mathiot, Michel Attal, et al.. (2008). Bortezomib/dexamethasone versus VAD as induction prior to autologous stem cell transplantion (ASCT) in previously untreated multiple myeloma (MM): Updated data from IFM 2005/01 trial. Journal of Clinical Oncology. 26(15_suppl). 8505–8505. 50 indexed citations
6.
Sonneveld, Pieter, Roman Hájek, Arnon Nagler, et al.. (2007). Impact of prior thalidomide (T) therapy on the efficacy of pegylated liposomal doxorubicin (PLD) and bortezomib (B) in relapsed/refractory multiple myeloma (RRMM). Journal of Clinical Oncology. 25(18_suppl). 8023–8023. 4 indexed citations
7.
Gouill, Steven Le, Pascaline Talmant, Cyrille Touzeau, et al.. (2007). The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica. 92(10). 1335–1342. 152 indexed citations
8.
Vigouroux, Sarah Le, et al.. (2000). Infections à dans les hémopathies malignes. La Revue de Médecine Interne. 21(11). 955–960. 9 indexed citations
9.
Moreau, Philippe, J. L. Harousseau, John Wijdenes, et al.. (2000). A combination of anti‐interleukin 6 murine monoclonal antibody with dexamethasone and high‐dose melphalan induces high complete response rates in advanced multiple myeloma. British Journal of Haematology. 109(3). 661–664. 69 indexed citations
10.
Moreau, Philippe, Nöel Milpied, Marie‐José Rapp, et al.. (1998). Early Intensive Therapy with Autologous Stem Cell Transplantation in High-Risk Hodgkin's Disease: Long-Term Follow-Up in 35 Cases. Leukemia & lymphoma. 30(3-4). 313–324. 3 indexed citations
11.
Ringdén, Olle, Myriam Labopin, Éliane Gluckman, et al.. (1997). Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. Transplantation Proceedings. 29(1-2). 733–734. 21 indexed citations
12.
Harousseau, J. L. & Bernard Klein. (1996). Utilisation de l'interféron alpha dans le myélome multiple. La Revue de Médecine Interne. 17(6). 488–495. 2 indexed citations
13.
Navenot, Jean‐Marc, Daniel J. Bernard, J. L. Harousseau, J. Y. Muller, & Dominique Blanchard. (1996). Expression of Glycosyl-Phosphatidylinositol-Linked Glycoproteins in Blood Cells from Paroxysmal Nocturnal Haemoglobinuria Patients a Flow Cytometry Study using CD55, CD58 and CD59 Monoclonal Antibodies. Leukemia & lymphoma. 21(1-2). 143–151. 32 indexed citations
14.
Avet‐Loiseau, Hervé, et al.. (1995). Leucémies aiguës néonatales: à propos de sept observations. Archives de Pédiatrie. 2(11). 1060–1066. 5 indexed citations
15.
Millot, Frédéric, Jean‐Louis Dhondt, Françoise Mazingue, et al.. (1993). Cerebrospinal Fluid Neopterin Levels in Children with Central Nervous System Leukemia. Leukemia & lymphoma. 9(4-5). 351–356. 9 indexed citations
16.
Wajcman, Henri, J. Kister, Danièlle Promé, et al.. (1993). Hb Saint Nazaire (β103[G5]Phe→Ile): A new example of polycythemia due to a hemoglobin variant with increased oxygen affinity. American Journal of Hematology. 44(1). 16–21. 15 indexed citations
17.
Moreau, Philippe, Jean‐Ralph Zahar, Nöel Milpied, et al.. (1993). Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection. Cancer. 72(11). 3223–3226. 43 indexed citations
18.
Moreau, Philippe, et al.. (1992). Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in the mixed lymphocyte reaction. Human Immunology. 33(3). 202–207. 32 indexed citations
19.
Milpied, Nöel, J. H. Bourhis, Richard Garand, & J. L. Harousseau. (1988). B CELL ALL IN AN ANTI‐HIV POSITIVE PATIENT: ACHIEVEMENT OF A COMPLETE RESPONSE WITH AGGRESSIVE CHEMOTHERAPY. British Journal of Haematology. 70(4). 501–502. 10 indexed citations
20.
Lacombe, C., Y. Blouquit, N. Arous, et al.. (1987). Hb Potomac [β101(G3)Glu→Asp] in a Polish Family Living in France. Hemoglobin. 11(1). 55–59. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. J. Ossenkoppele Breakdown of academic impact, for papers by A.-M. Stoppa Breakdown of academic impact, for papers by E. Papageorgiou Breakdown of academic impact, for papers by P Coser Breakdown of academic impact, for papers by Takafumi Matsushima Breakdown of academic impact, for papers by SN Wolff Breakdown of academic impact, for papers by Bernadette Corront Breakdown of academic impact, for papers by Roberto Sorasio Breakdown of academic impact, for papers by Neil Kogut Breakdown of academic impact, for papers by Carmen Pedro
Rankless by CCL
2026